Form 4: Elanco Animal Health Executive Reports Stock Transactions

Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, reports the acquisition of restricted stock units and stock options, as well as the disposition of shares to cover tax liabilities.

Summary

• On March 1, 2024, Jose Manuel Correia de Simas, an Executive Vice President at Elanco Animal Health, was granted 10,138 restricted stock units.
• These units vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
• On the same day, Correia de Simas also received 22,109 stock options, also vesting in three equal installments on the same dates.
• Additionally, 3,642 shares of common stock were disposed of at $16.03 to cover tax liabilities related to the vesting of previously awarded restricted stock units.
• Following these transactions, Correia de Simas directly owns 49,768 shares of Elanco Animal Health stock and 22,109 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions related to executive compensation. There are no explicit positive or negative indicators.

Positives

• The grant of restricted stock units and stock options to a key executive suggests a continued investment in the company's future and aligns the executive's interests with those of the shareholders.
• The vesting schedule of the grants (2025-2027) indicates a long-term commitment from the executive.

Industry Context

Executive compensation through stock options and restricted stock units is a common practice in the animal health industry to incentivize performance and retain key talent. This filing reflects standard compensation practices.

Comparison to Industry Standards

• Stock grants and options are a typical component of executive compensation packages in the pharmaceutical and animal health industries.
• Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans to align executive interests with shareholder value.
• The vesting schedules and grant sizes are generally comparable to industry norms for executives at similar levels.

Stakeholder Impact

• The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
• Employees may be indirectly affected by the incentive structure for executives.

Key Dates